JEFFREY JONES to Drug Resistance, Neoplasm
This is a "connection" page, showing publications JEFFREY JONES has written about Drug Resistance, Neoplasm.
Connection Strength
0.011
-
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med. 2004 Oct 07; 351(15):1513-20.
Score: 0.011